Vertex (VRTX) PT Lowered to $522 at BofA Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Evercore ISI on Vertex (VRTX): 'we see upside from here in 2025'
December 19, 2024 2:58 PM ESTEvercore ISI analyst Liisa Bayko reiterated an Outperform rating and $515.00 price target on Vertex (NASDAQ: VRTX).
The analyst comments "Below we share our thoughts and some nuggets from our back and forth with VRTX following the call today No change to our modelwe continue to view LSR as upside. Understanding the high PBO response, which was clinically significant in and of itself and higher than the P3 pregabalin LSR study (see chart inside). There was more use of NSAIDS in the low placebo responders, but we dont quite... More
